"BRAF Inhibition Opens Door to Development of Combination Targeted Therapy in Melanoma"
- Starts:
- 1:45 pm on Friday, October 12, 2012
- Ends:
- 2:45 pm on Friday, October 12, 2012
- Location:
- 670 Albany Street Room #107/108
- URL:
- http://www.bumc.bu.edu/busm-pathology/files/2008/09/Seminar-Fall-2012.pdf
Department of Pathology and Laboratory Medicine Seminar Series. Speaker - Keith T. Flaherty, MD
Director of Developmental Therapeutics
Massachusetts General Hospital Cancer Center
Harvard Medical School
